Smith & Nephew to acquire Ceterix Orthopaedics for up to $105M
Smith & Nephew agreed to acquire Ceterix Orthopaedics and its NovoStitch Pro knee repair device for up to $105 million, including $50 million upfront and $55 million in earn-outs.
ProductsNovoStitch Pro knee repair device
“Smith & Nephew today announces that it has agreed to acquire Ceterix Orthopaedics and its NovoStitch Pro knee repair device.”massdevice.com
- 3 sources
- massdevice.comSmith & Nephew to pay up to $105m for Ceterix Orthopaedics - MassDeviceBrad PerrielloDec 18, 2018
- hulldailymail.co.ukSmith & Nephew to spend up to £80m buying US medical tech firm - Hull LivePhil WinterJan 4, 2019
- thehealthcaretechnologyreport.comSmith & Nephew Acquires Ceterix for Potential $105M –Feb 13, 2019
Summarized from public sources; check the original articles before acting on it.